✦ LIBER ✦

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

✍ Scribed by Philip Meuleman; Jens Bukh; Lieven Verhoye; Ali Farhoudi; Thomas Vanwolleghem; Richard Y. Wang; Isabelle Desombere; Harvey Alter; Robert H. Purcell; Geert Leroux-Roels

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 198 KB
Volume: 53
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficient neutralizing activity of cockt

Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis a virus infection in vitro and in vivo

✍ Jingyuan Cao; Shufang Meng; Chuan Li; Yan Ji; Qingling Meng; Quanfu Zhang; Feng 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

## Abstract Hepatitis A virus (HAV) is the major pathogen responsible for acute infectious hepatitis A, a disease that is prevalent worldwide. Although HAV immunization effectively prevents infection, primary immunizations must be administered at least 2 weeks prior to HAV exposure. In contrast, pa

In vitro neutralization of hepatitis B v

In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen

✍ Ryu, Chun Jeih; Gripon, Philippe; Park, Heung Rok; Park, Sung Sup; Kim, Youn Kyu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 2 views

In vitro HBV infection and neutralization were assayed using an anti-preS1 murine monoclonal antibody (1B3) and anti-preS2 (H69K) and anti-S (CS131A) murine-human chimeric antibodies. The 1B3 (IgG1) and H69K (IgG1) was constructed previously and the CS131A was constructed for this study by expressin

Human monoclonal antibodies that react w

Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity

✍ Darren J. Schofield; Birke Bartosch; Yohko K. Shimizu; Tobias Allander; Harvey J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di

Prevalence of antibody against the core

Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma

✍ Yushiro Watanabe; Shizuko Harada; Izumu Saito; Tatsuo Miyamura 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 495 KB 👁 1 views

We have cloned the whole structural region of the hepatitis C virus (HCV) genome and transiently expressed the nucleocapsid protein in animal cells. Since the nucleotide sequences of this region of the HCV genome has been shown to be highly conserved among different HCV isolates, the assay detecting

Clinical evaluation of the signal-to-cut

Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China

✍ Shiji Wu; Yanling Liu; Liming Cheng; Botao Yin; Jing Peng; Ziyong Sun 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract The clinical diagnosis of hepatitis C virus (HCV) infection is important to direct an accurate course of therapy. Previous studies have reported a correlation between the signal‐to‐cutoff (S/CO) ratios of the anti‐HCV screening test and confirm HCV infections for American anti‐HCV scree

Antibody responses against B-cell epitop

Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides

✍ Maria G. Isaguliants; Anders Widell; Shumin M. Zhang; Anna Sidorchuk; Michael Le 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 1 views

## Abstract A rare collection of serum samples from patients with hepatitis C virus (HCV) infection followed up from the onset of clinical symptoms was acquired. RNA corresponding to the hypervariable region 1 (HVR1) of E2 protein of HCV isolated from nine patients was reverse‐transcribed, amplifie